TUNICRIS-julkaisut - Trepo

Viitteet 1-2 / 2

A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn’s disease patients in Finland

Sipponen, Taina; af Björkesten, Clas Göran; Hallinen, Taru; Ilus, Tuire; Soini, Erkki; Eberl, Anja; Heikura, Mikko; Kellokumpu, Mikko; Koskela, Ritva; Nielsen, Christian; Nuutinen, Heikki; Heikkinen, Markku; Suhonen, Ulla Maija; Tillonen, Jyrki; Wennerström, E. Christina M.; Borsi, Andras; Koivunen, Minni R.; Koivunen, Minni R. (04 / 2021)
article

<p>Background: Real-world evidence to support optimal ustekinumab dosing for refractory Crohn’s disease (CD) patients remains limited. Data from a retrospective nationwide chart review study was utilized to explore ...
Real-life treatment persistence and treatment outcomes of Finnish patients with inflammatory bowel disease receiving vedolizumab as first-line biological treatment

Ylisaukko-oja, Tero; af Björkesten, Clas Göran; Eberl, Anja; Nuutinen, Heikki; Jussila, Airi; Molander, Pauliina; Koskela, Ritva; Blomster, Timo; Pajala, Markku; Ilus, Tuire; Haiko, Paula; Kovac, Bianca; Silvola, Saija; Smith, Sarah; Jokelainen, Jari; Sipponen, Taina (30.06.2024)
article

<p>Purpose: To analyze treatment persistence and treatment outcomes of vedolizumab as first-line biological treatment in Crohn's disease (CD) and ulcerative colitis (UC) patients in a Finnish real-world setting. ...